We found that HNF1B could be epigenetically repressed by EZH2 in prostate cancer cell lines, and its expression is reversely correlated with EZH2 expression in several cohorts of prostate cancer samples, including TCGA database and in-house collection. The gene discussed is EZH2; the disease is prostate carcinoma.